Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators.
- DOI
- 10.3389/fimmu.2025.1531447
- Published
- 2025
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2025.1531447,
title = {Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators.},
author = {Hecker M and Fitzner B and Ludwig-Portugall I and Bohne F and Heyland E and Klehmet J and Grothe M and Schwab M and Winkelmann A and Meister S and Dudesek A and Wurm H and Ayzenberg I and Kleiter I and Trebst C and Hümmert MW and Neumann B and Eulitz K and Koczan D and Zettl UK},
year = {2025},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2025.1531447},
url = {https://doi.org/10.3389/fimmu.2025.1531447}
}RIS
TY - JOUR TI - Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators. AU - Hecker M AU - Fitzner B AU - Ludwig-Portugall I AU - Bohne F AU - Heyland E AU - Klehmet J AU - Grothe M AU - Schwab M AU - Winkelmann A AU - Meister S AU - Dudesek A AU - Wurm H AU - Ayzenberg I AU - Kleiter I AU - Trebst C AU - Hümmert MW AU - Neumann B AU - Eulitz K AU - Koczan D AU - Zettl UK PY - 2025 JO - Frontiers in immunology DO - 10.3389/fimmu.2025.1531447 UR - https://doi.org/10.3389/fimmu.2025.1531447 ER -
APA
M, H., B, F., I, L., F, B., E, H., J, K., M, G., M, S., A, W., S, M., A, D., H, W., I, A., I, K., C, T., MW, H., B, N., K, E., D, K., & UK, Z. (2025). Apheresis for the treatment of relapses in MS and NMOSD: reduced antibody reactivities, gene expression changes and potential clinical response indicators.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2025.1531447
Source records
- pubmed · retrieved 2026-09-27T15:08:12.397Z